Christopher McCarthy - 21 Apr 2023 Form 3 Insider Report for INTERPACE BIOSCIENCES, INC. (IDXG)

Role: Principal Financial Officer
Signature: /s/ Christopher McCarthy
Issuer symbol: IDXG
Transactions as of: 21 Apr 2023
Net transactions value: $0
Form type: 3
Filing time: 03 May 2023, 15:17:10 UTC
Next filing: 01 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IDXG	Common Stock						7,310	21 Apr 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IDXG	Stock Option (right to buy)							21 Apr 2023	Common Stock	2,500	$6.00	Direct	F1
holding	IDXG	Restricted Stock Units							21 Apr 2023	Common Stock	5,000	$0.000000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-third of the options will vest and become exercisable on 3/10/2022, and the remaining portion will vest and become exercisable in 24 equal monthly installments commencing on the first day of April 2022, subject to continued employment through each such vesting date.
F2	One-third of the restricted stock units will vest commencing on December 1, 2022 and the remaining two-thirds will vest in equal yearly installments thereafter for the next two years.